Most Cancer Drugs Approved With Immature OS Data Don’t Show OS Benefit Later On
-
Biden Leans Into Health Care, Asking Voters to Trust Him Over TrumpResults of a KFF survey suggest that independent voters trust Biden more than Trump to ensure access to affordable health insurance and maintain protections for people with preexisting conditions.
-
Greater FDA Oversight of Laboratory-Developed Tests: A Needed Change?Some experts have said greater oversight of laboratory-developed tests will stifle innovation and interfere with cancer care, but others say this oversight is needed to protect patients.
-
ASCO Updates Guidelines on Palliative CareExperts recommend that patients with advanced cancer be referred to specialized interdisciplinary palliative care teams soon after diagnosis.
-
Reconceptualizing Women’s Health: Using Trans-Inclusive Language for More Equitable CareTrans-inclusive language can help clinicians promote accessible and equitable care in traditional women's health care spaces.
-
April 2024 Recap: Oncology Drug Pipeline UpdatesIn April, the US Food and Drug Administration announced pipeline updates for several drugs intended to treat cancers.
Clinical Tools
Powered by
Powered by
Drug Look-up
Select a category
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancers
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic Cancers
- Head and neck cancer
- Kaposi's sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
- Solid tumors
Drug Comparison Charts
Select a category
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancers
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic Cancers
- Head and neck cancer
- Kaposi's sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
- Solid tumors
Calculators
MORE CLINICAL TOOLS
Select a category
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancers
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic Cancers
- Head and neck cancer
- Kaposi's sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
- Solid tumors
More From
EXPLORE OUR NETWORKRitux 3 Regimen Provides Patients With Pemphigus With Sustained Remission
Efficacy of a Co-Located Bridging Recovery Initiative for Opioid Use Disorder
US Oncologists, Hematologists Receive More Industry Payments Than Their Peers
FDA Withdraws Approval of Pepaxto for Multiple Myeloma
PIDS Updates Guidance on COVID-19 Management in Children, Adolescents
- Bladder Cancer
- Breast Cancer
- Central Nervous System Cancers
- Endocrine Cancers
- Gastrointestinal Cancers
- General Medicine
- General Oncology
- Genitourinary Cancers
- Gynecologic Cancers
- Head and Neck Cancers
- Hematologic Cancers
- Leukemia
- Lung Cancer
- Lymphoma
- Myeloma
- Pediatric Cancer
- Prostate Cancer
- Renal Cell Carcinoma
- Sarcomas
- Skin Cancers